Douglas Boothe Insider Trading $IPXL Impax Laboratories, LLC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Douglas Boothe.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Douglas Boothe. Douglas Boothe is President and CEO in AKORN INC ($AKRN.PK) and President, Generics Division in IMPAX LABORATORIES INC ($IPXL) and EVP & GM Perrigo Pharma in PERRIGO CO ($PRGO) and EVP & GM Perrigo Pharma in PERRIGO Co plc ($PRGO).
Douglas Boothe in Impax Laboratories, LLC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Douglas Boothe: President, Generics Division
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 08 2018
$IPXL Market Capitalization: $952.26M
$IPXL Previous Close: $13.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Douglas Boothe in Impax Laboratories, LLC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKRN.PK, IPXL, PRGO, PRGO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 08 2018 | IPXL | Impax Laboratories ... | Boothe Douglas | President, Generics ... | Option Exercise | D | 9.35 | 56,232 | 525,769 | 0 | |
| May 08 2018 | IPXL | Impax Laboratories ... | Boothe Douglas | President, Generics ... | Option Exercise | D | 24.42 | 50,500 | 1,233,210 | 0 | |
| May 08 2018 | IPXL | Impax Laboratories ... | Boothe Douglas | President, Generics ... | Sell | D | 0.00 | 41,756 | 0 | 0 | 41.8 K to 0 (-100.00 %) |
| May 08 2018 | IPXL | Impax Laboratories ... | Boothe Douglas | President, Generics ... | Sell | D | 0.00 | 14,145 | 0 | 0 | 14.1 K to 0 (-100.00 %) |
| Mar 05 2018 | IPXL | IMPAX LABORATORIES ... | Boothe Douglas | President, Generics ... | Payment of Exercise | F | 19.50 | 2,041 | 39,800 | 78,549 | 80.6 K to 78.5 K (-2.53 %) |
| Aug 02 2017 | IPXL | IMPAX LABORATORIES ... | Boothe Douglas | President, Generics ... | Payment of Exercise | F | 17.85 | 5,282 | 94,284 | 80,590 | 85.9 K to 80.6 K (-6.15 %) |
| Mar 06 2017 | IPXL | IMPAX LABORATORIES ... | Boothe Douglas | President, Generics ... | Option Exercise | A | 9.35 | 56,232 | 525,769 | 56,232 | |
| Mar 06 2017 | IPXL | IMPAX LABORATORIES ... | Boothe Douglas | President, Generics ... | Grant | A | 0.00 | 23,272 | 0 | 85,872 | 62.6 K to 85.9 K (+37.18 %) |
| Aug 31 2016 | IPXL | IMPAX LABORATORIES ... | Boothe Douglas | President, Generics ... | Option Exercise | A | 24.42 | 50,500 | 1,233,210 | 50,500 | |
| Aug 31 2016 | IPXL | IMPAX LABORATORIES ... | Boothe Douglas | President, Generics ... | Grant | A | 0.00 | 62,600 | 0 | 62,600 | 0 to 62.6 K |
Page: 1